ctDNA Could Aid in Treatment Escalation and De-escalation Decisions in Kidney Cancer

1 year ago 38
Alan Tan, MD, discusses how utilizing circulating tumor DNA may provide valuable insight into when to escalate vs de-escalate treatment for patients with renal cell carcinoma.
Read Entire Article